Dr Jessamy Tiffen
Acting Deputy Director
Head, Centre for Cancer Innovations
Laboratories
Dr Jessamy Tiffen leads the Epigenetics of Melanoma Program at the Centenary Institute and is a recipient of a prestigious Melanoma Academy Scholar Award from the U.S. Congressionally Directed Medical Research Programs. Her research focuses on epigenetic regulation and biological sex differences in cancer, with publications in leading journals including Nature Genetics, The Lancet Oncology, JNCI, and Cancer Research.
She completed her PhD in Cancer Genetics at the University of Sydney and trained at the Wellcome Trust Sanger Institute in Cambridge, UK. Dr Tiffen established her independent research group in 2018 and is also an Adjunct Senior Lecturer at the University of Sydney. Her work has been supported by major funding bodies including Cancer Council NSW, Tour de Cure, and the Australian Melanoma Research Foundation.
